Hybrid Conferencee

International Conference on Vaccine Development and Infectious Disease Prevention (ICVDIDP - 27)

4th - 5th March 2027 | Kumasi, Ghana
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 4–5 March 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 5 SDGs SDGs 3, 4, 9, 10 and 17
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

4 MAR 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Innovations in Vaccine Development
    34
    Track Overview

    This track focuses on the latest advancements in vaccine technology and development processes. It aims to explore novel approaches and methodologies that enhance vaccine efficacy and accessibility.

    Track 02
    Clinical Trials in Vaccine Research
    39
    Track Overview

    This session will delve into the design, implementation, and outcomes of clinical trials for new vaccines. Participants will discuss challenges and best practices in evaluating vaccine safety and effectiveness.

    Track 03
    Immunological Mechanisms in Infectious Diseases
    39
    Track Overview

    This track aims to elucidate the immunological responses to various infectious agents. It will cover topics such as immune evasion strategies employed by pathogens and the role of host immunity in disease outcomes.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Public Health Strategies for Disease Prevention
    34
    Track Overview

    This session will examine effective public health interventions aimed at preventing infectious diseases. Discussions will include vaccination campaigns, health education, and community engagement strategies.

    Track 05
    Novel Vaccines for Emerging Infectious Diseases
    39
    Track Overview

    This track will highlight the development of vaccines targeting newly emerging infectious diseases. It will focus on the rapid response mechanisms and innovative technologies used in vaccine creation.

    Track 06
    Pathogen Biology and Vaccine Targeting
    39
    Track Overview

    This session will explore the biological characteristics of various pathogens and how these traits influence vaccine design. Participants will discuss the implications of pathogen biology on vaccine efficacy and safety.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
View Day 02 Schedule →
Day 02

Keynote, Technical Sessions & Awards

5 MAR 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Outbreak Prevention and Response Strategies
    34
    Track Overview

    This track will focus on strategies for preventing and responding to infectious disease outbreaks. It will cover surveillance systems, rapid response frameworks, and the role of vaccines in outbreak control.

    Track 08
    Vaccine Safety and Public Perception
    34
    Track Overview

    This session will address the critical aspects of vaccine safety and the factors influencing public perception. Discussions will include risk communication, misinformation, and strategies to enhance vaccine confidence.

    Track 09
    Disease Modeling and Predictive Analytics
    39
    Track Overview

    This track will explore the use of disease modeling and predictive analytics in understanding infectious disease dynamics. Participants will discuss how these tools can inform vaccine development and public health interventions.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Global Collaboration in Vaccine Research
    317
    Track Overview

    This session will highlight the importance of international collaboration in vaccine research and development. It will focus on partnerships between governments, academia, and industry to address global health challenges.

    Track 11
    Ethical Considerations in Vaccine Development
    310
    Track Overview

    This track will examine the ethical implications surrounding vaccine research and deployment. Discussions will include informed consent, equitable access, and the responsibilities of researchers and policymakers.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
← Back to Day 01 Schedule
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities 17 Partnerships for the Goals

Be Part of ICVDIDP-27

Submit your research or complete your conference registration.

Submit Abstract / Paper Complete Registration
Copyrights © . All Rights Reserved. Terms & Conditions